The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Philippe Cottagnoud

Department of Internal Medicine

Inselspital

Switzerland

[email]@insel.ch

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Internal Medicine, Inselspital, Switzerland. 2000 - 2008

References

  1. Daptomycin: a new treatment for insidious infections due to gram-positive pathogens. Cottagnoud, P. Swiss. Med. Wkly (2008) [Pubmed]
  2. Preincubation of pneumococci with beta-lactams alone or combined with levofloxacin prevents quinolone-induced resistance without increasing intracellular levels of levofloxacin. Cottagnoud, P., Johnson, M., Cottagnoud, M., Piddock, L. Antimicrob. Agents Chemother. (2005) [Pubmed]
  3. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. Flatz, L., Cottagnoud, M., Kühn, F., Entenza, J., Stucki, A., Cottagnoud, P. J. Antimicrob. Chemother. (2004) [Pubmed]
  4. New therapies for pneumococcal meningitis. Cottagnoud, P.H., Täuber, M.G. Expert. Opin. Investig. Drugs (2004) [Pubmed]
  5. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Cottagnoud, P., Pfister, M., Acosta, F., Cottagnoud, M., Flatz, L., Kühn, F., Müller, H.P., Stucki, A. Antimicrob. Agents Chemother. (2004) [Pubmed]
  6. Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Cottagnoud, P., Cottagnoud, M., Täuber, M.G. Antimicrob. Agents Chemother. (2003) [Pubmed]
  7. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Cottagnoud, P., Pfister, M., Cottagnoud, M., Acosta, F., Täuber, M.G. Antimicrob. Agents Chemother. (2003) [Pubmed]
  8. The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis. Cottagnoud, P., Gerber, C.M., Majcherczyk, P.A., Acosta, F., Cottagnoud, M., Neftel, K., Moreillon, P., Täuber, M.G. Infect. Immun. (2003) [Pubmed]
  9. Fluoroquinolones in the Treatment of Meningitis. Cottagnoud, P., Täuber, M.G. Curr. Infect. Dis. Rep (2003) [Pubmed]
  10. Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis. Cottagnoud, P., Cottagnoud, M., Acosta, F., Flatz, L., Kühn, F., Stucki, A., Entenza, J. Eur. J. Clin. Microbiol. Infect. Dis. (2003) [Pubmed]
  11. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Cottagnoud, P., Acosta, F., Cottagnoud, M., Pfister, M., Täuber, M.G. Antimicrob. Agents Chemother. (2002) [Pubmed]
  12. Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Cottagnoud, P., Gerber, C.M., Cottagnoud, M., Täuber, M.G. Antimicrob. Agents Chemother. (2002) [Pubmed]
  13. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis. Cottagnoud, P., Acosta, F., Cottagnoud, M., Täuber, M.G. J. Antimicrob. Chemother. (2002) [Pubmed]
  14. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis. Cottagnoud, P., Acosta, F., Cottagnoud, M., Täuber, M.G. Antimicrob. Agents Chemother. (2002) [Pubmed]
  15. Cellular and molecular aspects of drugs of the future: meropenem. Cottagnoud, P. Cell. Mol. Life Sci. (2002) [Pubmed]
  16. Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. Cottagnoud, P., Entenza, J.M., Cottagnoud, M., Que, Y.A., Moreillon, P., Taüber, M.G. BMC Microbiol. (2001) [Pubmed]
  17. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Cottagnoud, P., Acosta, F., Cottagnoud, M., Neftel, K., Täuber, M.G. Antimicrob. Agents Chemother. (2000) [Pubmed]
  18. Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. Cottagnoud, P., Gerber, C.M., Acosta, F., Cottagnoud, M., Neftel, K., Täuber, M.G. J. Antimicrob. Chemother. (2000) [Pubmed]
 
WikiGenes - Universities